HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide
Study #: IB19-02c
Study Status: Published
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MR, Modi D, Grunwald MR, Nishihori T, Kuxhausen M, Fingerson S, McKallor C, Bashey A, Kasamon YL, Bolon Y-T, Saad A, McGuirk J, Paczesny S, Gadalla SM, Marsh SGE, Shaw BE, Spellman SR, Lee SJ, Petersdorf EW.
Blood. 2022, Mar 10: 139(10): 139(10):1452-1468. doi: 10.1182/blood.2021013443. Epub 2021, Nov 01. PMCID:PMC8914182.
PMID: 34724567
Abstract